Understanding the Link Between Gut Health and Depression
Treatment-resistant depression (TRD) and inflammatory subtypes of depression are increasingly associated with gut microbiome imbalance and chronic low-grade inflammation. While conventional antidepressants target neurotransmitters such as serotonin and dopamine, emerging research shows that the gut microbiome plays a central role in regulating these same pathways.
Approximately 90% of serotonin is produced in the gut. When microbial diversity is reduced—a condition known as dysbiosis—immune activation may increase, inflammatory cytokines may rise, and communication along the gut–brain axis can become disrupted. For some patients, this inflammatory burden may contribute to persistent depressive symptoms that do not fully respond to medication alone.
What Is Inflammatory Depression?
Inflammatory depression is a subtype characterized by elevated inflammatory markers, fatigue, brain fog, poor stress tolerance, and coexisting gastrointestinal symptoms such as bloating, IBS, or food sensitivities. Research suggests that immune activation can interfere with neurotransmitter production and neuroplasticity, potentially reducing response to standard antidepressant therapy.
Identifying this subtype requires structured evaluation rather than symptom suppression alone.
Our Gut–Brain Evaluation Process
At C-GABA, patients with treatment-resistant or inflammatory depression undergo comprehensive assessment, which may include:
- Detailed psychiatric and medical history
- Stool microbiome analysis
- Inflammatory and metabolic markers
- Gut permeability evaluation
- Dietary and lifestyle review
This multidisciplinary approach helps determine whether gut dysbiosis or systemic inflammation may be contributing to mood symptoms.
Integrative Treatment Options Including Microbiome Therapy
Treatment plans are personalized and coordinated with psychiatric care. Interventions may include dietary optimization, anti-inflammatory strategies, metabolic regulation, and targeted microbiome modulation.
In carefully selected cases with documented severe dysbiosis, Faecal Microbiota Transplantation (FMT) may be considered within strict clinical protocols. FMT is not a cure for depression but may serve as part of a broader therapeutic framework.
Frequently Asked Questions
Can gut problems cause depression?
Emerging evidence shows that gut microbiome imbalance may influence inflammation and neurotransmitter pathways involved in depression.
What makes depression treatment-resistant?
Depression is considered treatment-resistant when adequate trials of standard therapies fail to produce meaningful improvement.
Is FMT approved for depression?
FMT is approved for recurrent C. difficile infection and may be considered investigational for other conditions.